A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-Medicated Rejection in Kidney Transplant Recipients (IMAGINE)

Project: Research

StatusActive
Effective start/end date2/12/191/12/24

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • kidney transplantation